LexDanaLexDanabeta
Inventor

Jacques Dumas

Inventor
Bethany, CT, US

Overview

59→
Patents
1994–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 59 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07CAcyclic or carbocyclic compounds10%
A61KPreparations for medical, dental or toiletry purposes9%
A01NPreservation of bodies of humans or animals or plants or parts thereof6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
Y02ATechnologies for adaptation to climate change4%
C07BGeneral methods of organic chemistry1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
A61LMethods or apparatus for sterilising materials or objects in general1%
PatentTitleYear
10,653,684Aryl ureas with angiogenisis inhibiting activity20209,181,188'Aryl ureas as kinase inhibitors'20158,841,330'Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors'20148,796,250'Diaryl ureas for diseases mediated by PDGFR'20148,637,553'Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions'20148,618,141'Aryl ureas with angiogenesis inhibiting activity'20138,580,798'Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders'20138,431,695'Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases'20138,242,147'Aryl ureas with angiogenisis inhibiting activity'20128,207,172'Pyrimidinothienoindazoles useful for the treatment of hyperproliferative disorders'20128,207,166'Substituted pyrazolyl urea derivatives useful in the treatment of cancer'20128,124,630'ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors'20128,110,587'Aryl ureas as kinase inhibitors'20128,076,488'Bicyclic urea derivatives useful in the treatment of cancer and other disorders'20118,071,616'Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors'20117,977,333'Substituted pyridines and pyridazines with angiogenesis inhibiting activity'20117,928,239'Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas'20117,928,227'2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders'20117,897,623'ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors'20117,838,524'Substituted pyrazolyl urea derivatives useful in the treatment of cancer'20107,838,541'Aryl ureas with angiogenesis inhibiting activity'20107,803,956'Benzofuran derivatives useful for treating hyper-proliferative disorders'20107,750,017'Heterocycles'20107,678,811'Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors'20107,659,412'Benzofuran derivatives useful for treating hyper-proliferative disorders'20107,625,915'Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas'20097,585,888'Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders'20097,557,129'Cyanopyridine derivatives useful in the treatment of cancer and other disorders'20097,528,255'Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors'20097,517,880'Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas'20097,420,066'Benzofuran derivatives useful for treating hyper-proliferative disorders'20087,384,947'Fused tricyclic heterocycles useful for treating hyper-proliferative disorders'20087,371,763'Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas'20087,351,735'Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders'20087,351,834'ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors'20087,329,670'Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas'20087,238,701'Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders'20077,235,576'Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors'20077,144,885'Fused tricyclic heterocycles useful for treating hyper-proliferative disorders'20066,943,172'Rho-kinase inhibitors'20056,924,290'Rho-kinase inhibitors'20056,919,371'2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists'20056,903,101'Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity'20056,787,651'Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR- binding agents'20046,689,883'Substituted pyridines and pyridazines with angiogenesis inhibiting activity'20046,660,752'2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists'20036,569,810'Cyclopentane-1,3-dione derivatives'20036,515,184'Cyclopentane-1,3-dione derivatives, herbicidal and pesticidal compositions containing them, methods of using them to combat pests and weeds and process for the preparation thereof'20036,420,341'Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors'20026,150,304'2-aryl-cyclopentane-1,3-dione derivatives'20006,136,842'Sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives'20006,100,220'Thiophene derivatives'20006,025,383'Substituted thiophene derivatives as pesticides and herbicides'20005,945,444'3-aryl-4-hydroxy-.DELTA..sup.3 -dihydrothiophenone derivatives'19995,840,661'2-aryl cyclopentane-1,3-dione derivatives'19985,808,135'2-(2,4,6-trimethyl phenyl)cyclopentane-1,3-dione derivatives'19985,807,805'Substituted thiophene derivatives as pesticides and herbicides'19985,446,225'Palladium catalyzed akylative cyclization useful in syntheses of Vitamin D and analogues'19955,292,977'Palladium catalyzed alkylative cyclization useful in synthesis of vitamin D and analogues'1994

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2003Patents assigned to BAYER AG (9)· patent assignee history
1998–2014Based in Orange, CT, US· patent location history
1998–2000Based in Koln, DE· patent location history
2003–2010Patents assigned to BAYER PHARMACEUTICALS CORP (18)· patent assignee history
2003–2015Based in Bethany, CT, US· patent location history
2008–2020Patents assigned to BAYER HEALTHCARE LLC (23)· patent assignee history
2010–2012Based in Waltham, MA, US· patent location history
2011–2015Patents assigned to DUMAS JACQUES (14)· patent assignee history
2011–2015Patents assigned to SCOTT WILLIAM J (8)· patent assignee history
2011–2020Based in Carlisle, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BAYER HEALTHCARE LLC232008–2020
BAYER PHARMACEUTICALS CORP182003–2010
DUMAS JACQUESself142011–2015
BAYER AG91998–2003
SCOTT WILLIAM J82011–2015
Locations
LocationPatentsSpan
Bethany, CT, US282003–2015
Orange, CT, US181998–2014
Carlisle, Massachusetts, US42011–2020
Koln, DE31998–2000
Waltham, Massachusetts, US22010–2012